The device will monitor air quality, CO2 levels in the blood, physical activity, breathing, emotional states and other stimuli to identify asthma triggers.
Featuring medical-grade accuracy, the device has been launched on crowdfunding website Indiegogo, with the goal of raising $50,000 in a month-long campaign.
Called My Asthma Pal, the application runs of iOS and Android devices, providing children and their parents with a mobile tool to track and manage asthma.
Also the three studies Adherium has conducted have found a 14.9% increase in lung function and a 37% reduction in oral steroid usage.
Said app enables asthma patients to participate in a study by using their iPhones; the new features enable participants to use the app with their physicians.
FDA-approved marketing claims of improved adherence and reduction in exacerbations address key unmet needs in respiratory health.
With Adherium's smartphone-connected device, the medication adherence increases by up to 59% in adults and 180% in children with asthma.
The Bluetooth-enabled, smartphone-connected device measures critical lung function with comparable accuracy to clinical-grade spirometers.
LifeMap Solutions claims that Asthma Health app users as engaged (or more) with Asthma Health as they are with games and social networks.
The company offers the Asthma Whistle and the accompanying app plus cloud solution that help parents track their child's asthma and prevent exacerbations.